1. General information. Editorial Policy
2. Preparation and submission of manuscripts
3. Review process of manuscripts
4. Guarantees and responsibility of the author
5. Ethics in publications: conflicts of interest
6. Scientific fraud



The Journal of Osteoporosis and Mineral Metabolism (ROMM) (www.revistadeosteoporosisymetabolismomineral.es), is the official body of scientific expression of the “Spanish Society for Bone and Mineral Metabolism Research” (SEIOMM). The Magazine is published online and is freely offered through its website. It is published on a quarterly basis (4 issues per year), with a varying number of articles. The third issue of the year, autumn, always publishes communications from the annual SEIOMM Congress. The Journal publishes works in Spanish and English. Papers received in Spanish are translated into English for publication in a parallel English version.

The management and elaboration of the ROMM is carried out by two committees and a publishing company:

  • The Management Committee officially and legally represents the Journal, directs its activities and contents, carries out or proposes actions for its improvement and is responsible for the registration and review process of the manuscripts. It is also responsible for the final decision on the publication of manuscripts and decides on the content of each number.
  • The Editorial Committee, made up of the President of the SEIOMM and a group of researchers and experts of international relevance, has a consultative and advisory function to the Management Committee.
  • The Publishing Company is contracted by SEIOMM and, with Editorial Committee supervision, is responsible for receiving manuscripts, their layout and publication, as well as maintaining and updating the Journal’s website.

A) Policy of originality or non-prior publication. The articles published in the ROMM must be original and must not have been published previously. In case of publication once sent to the journal, the authors must notify it and withdraw the article. When submitting their texts, the authors must not provide the details of their findings to the media before their work is submitted for peer review and, where appropriate, published.

B) Online open access policy. The ROMM does not have an embargo or grace period, nor does it require any registration to access its contents. Each article can be read, as “Preview of next numbers” or in its corresponding number once it is definitively published. All articles, both those published in Spanish and English, can be freely read or downloaded at no cost. The Journal does not charge authors for the delivery or publication of their articles.

C) Self-archiving policy and reuse of published articles. The authors or third parties authorized by them are allowed to deposit the files corresponding to the articles published in the ROMM in institutional repositories, thematic repositories or on personal pages.

D) Peer review policy. Each manuscript will be reviewed by at least two experts in the particular field of specialization of the submitted manuscript. For this and in order to avoid subjective assessments, the manuscript will be sent without the name or affiliation of the authors. The ROMM will guarantee strict compliance with double anonymity in this process.

E) Publication policy. Of the manuscripts published as “Advance of next issues” the Management Committee will decide which ones and at what time they will be published in the different issues of the ROMM. The ROMM handles the English translation of all manuscripts. Typically, the review and posting process will be completed within three months.

F) The role of the ROMM Management and Publisher in the review and approval of published material: The Management Committee directs and supervises the policies of the ROMM and is responsible for maintaining its scientific and literary quality. Their first obligation is to ensure that all authors receive confidential and unbiased feedback on their work. The Management Committee, the Editorial Committee and the Publisher will not reveal any personal information about the manuscripts received. The Management Committee and the Editorial Committee will not manage those works that have or are suspected of having some kind of conflict of interest. In such cases, the Steering Committee will decide after consulting with the authors themselves.

G) The Steering Committee, the Editorial Committee or the Publisher will not use any type of information from a manuscript sent, but not published, without the written permission of its author.

H) Responsibility Policy. The judgments and opinions expressed in the articles published in the ROMM are exclusively attributable to their author or authors and never to the Journal Committees. Both ROMM and SEIOMM decline any type of responsibility in this regard.

I) Advertising policy. All advertisements intended to be published in the Magazine are subject to the approval of the SEIOMM Board of Directors, which will hear the opinion of the Management Committee. The aforementioned Board reserves the right to reject or cancel any advertisement at any time. Since ROMM is an exclusively digital magazine, advertising will be shown on its website and not inside the numbers. All ads must clearly identify the advertiser by brand or signature. In any case, neither the SEIOMM nor the ROMM support any product that is advertised in the Magazine, nor do they guarantee the statements made by the manufacturer about said product or service, which are their sole responsibility. SEIOMM and ROMM are not responsible for possible errors produced when publishing any accepted advertisement.

J) Policy on conflict of interest, human and animal rights and informed consent for publications. The Editorial Board reserves the right to reject manuscripts that do not meet acceptable standards of research behavior as determined by the Belmont Report, the Declaration of Helsinki, and the Geneva Convention.

K) Human research subjects. All studies carried out with human beings or human tissues must be in accordance with the principles set forth in the Declaration of Helsinki for publication and must have been formally approved by an Ethics, Clinical Trials Committee or equivalent. All manuscripts must expressly indicate that such approval was obtained. In the text and data in tables and figures, subjects should be identified by numbers or letters instead of their names or initials. Photographs of patient faces may be included only if they are scientifically relevant. The authors must obtain written authorization from the patient for the use of such photographs, expressly indicating such data in the submitted manuscript.

L) Guidelines for the care and use of experimental animals. The ROMM requires that studies involving the use of animals be carried out under standardized animal protection regulations. The adequacy of the experimental procedures, as well as the species and number of animals used, must be considered in the design of any study. All research animals must be acquired and used in accordance with international and national laws and institutional regulations.

M) Policy on the process for handling cases that require corrections, retractions and editorial reports. ROMM follows the recommendations of the International Committee of Medical Journal Editors on scientific misconduct, expressions of interest, and retraction: http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/scientific-misconduct-expressions-of-concern-and-retraction.html

N) Authorship policy. It is the responsibility of each person who appears as the author of an article published in the Journal to have contributed in a significant and identifiable way to the design, execution, analysis or writing of the article in question. All authors will agree on all aspects of the original work. For more information on these sections, consult the following link: http://www.icmje.org/

^Top of page

By submitting a manuscript, it is understood that, if published, the authors assign to the Journal the rights of reproduction and subsequent distribution of their manuscript in any medium.



 Manuscripts must be prepared following the recommendations of the International Committee of Medical Journal Directors (available at: www.icmje.org), and emailed to: romm@ibanezyplaza.com. Two versions of the text will be sent: one anonymous version for peer review of the text and another with the reference and precise identification of the authors.

Submitted manuscripts must conform to one of the following sections:

1. Originals. Any clinical or experimental research work of any kind related to bone mineral metabolism will be considered original.

2. Clinical notes. Description of one or more clinical cases of exceptional observation that represent an important contribution to the knowledge of bone mineral metabolism.

3. Short originals. These will be clinical or experimental works which, due to their special characteristics (reduced number of observations, research works with very specific objectives and results, descriptive epidemiological studies, among others), cannot be published as originals themselves, but in more abbreviated form.

4. Osteology images. Images (radiological, pathological, clinical, etc.) will be accepted in this section, up to a maximum number of 4, related to the field of Osteology and mineral metabolism. The images must be accompanied by an explanatory text.

5. Letters to the Editor. In this section, those letters that refer to works previously published in the ROMM and that provide opinions, observations or experiences that, due to their characteristics, can be summarized in a short text, will be published.

6. Other sections. The ROMM includes other sections (Editorials, Reviews and Documents or Special Articles), whose contents will be commissioned by the management. Authors who, on their own initiative, wish to collaborate in any of these sections must previously consult the ROMM management.

6.1. Reviews. They will preferably be requested by the Director, although they can also be sent on the authors’ initiative. In the latter case, they will be subject to a review process.

6.2. Editorials. They will be requested by the Director.

6.3. Special documents. All those documents and articles that could make some scientific contribution to the field of bone mineral metabolism and whose characteristics do not allow their inclusion in any of the previous sections of the ROMM will be included in this section. The Editorial Committee will decide how to publish these documents and reserves the right to modify them to adapt them to the format of the Journal.

Presentation letter

All manuscripts must be accompanied by a cover letter stating: 1) the section of the ROMM in which they are to be published; 2) a brief explanation of the original contribution and the relevance of the work in the field of bone metabolic disease; 3) the statement that the manuscript is original and has not been simultaneously submitted to any other journal; and 4) the declaration that all the instructions of this guide have been observed and, where appropriate, the specific ones that the Journal’s Management may specify on a specific and exceptional basis. In addition, the cover letter will indicate the contribution of each of the authors to the submitted work (design, field work, analysis and interpretation of data, writing and bibliographic search, etc.).

Preparation of the manuscripts

Manuscripts must be written in Spanish or English. The full text of the manuscript, from the title page to the references, must be included in a Word document with the pages numbered. Only common abbreviations in the field of Medicine will be used. Abbreviations will be avoided in the title and in the abstract of the work. The first time an abbreviation appears, it must be preceded by the full term to which it refers, except in the case of common measurement units, which will be expressed according to the International System. The works must include the information required below, and this will be ordered as follows: title page and authors, abstract page and keywords, main text (introduction, material and methods, results, discussion and bibliography), tables and figures. If necessary, the tables and figures may be included in another attached file, in TIFF, EPS, JPEG, or GIF format with their respective titles and numbering.

  1. Sections of the manuscripts

1.1. Title page and authors: will include the following information:

– The title must adequately describe the content, be brief, clear and informative and include the full name and surnames of the authors, separated or hyphenated, according to the authors’ preference. The maximum number of authors will depend on the type of manuscript; 10 authors for full original articles, no more than 6 for brief clinical and original notes and 3 authors for osteologic images, editorial notes and revisions. In the case of special documents, the maximum number of signatories will be agreed upon with the journal managing staff.

– The name of the department(s) or service(s) and the institution(s) to which the authors belong or are linked. Academic position or professional category of the authors should not be included.

The full name, e-mail (if available) and postal address of the author to whom correspondence should be directed will also be included separately. This author will also be responsible for proofreading.

It also includes the acknowledgment of any grant or economic aid, as well as the declaration of the existence or not of conflicts of interest of each one of the authors and of having observed the precepts of the Declaration of Helsinki on clinical studies; and, where appropriate, the declaration of having observed the regulations corresponding to the care and use of experimental animals.

1.2. SUMMARY AND KEYWORDS. The structured abstract must appear on the second page of the manuscript and its maximum length will be 250 words in the case of originals and reviews and 150 in clinical notes and brief originals. The rest of the manuscripts will not require an abstract. It will have the following headings: Objectives, indicating the fundamental purpose of the work; Material and methods, explaining the study design, the evaluation criteria of the diagnostic tests and the temporal direction (retrospective or prospective). The patient selection procedure, the inclusion and/or exclusion criteria, and the number of patients who start and finish the study will be mentioned. If it is an experimental work, the number and type of animals used will be indicated; Results, where the most relevant and significant results of the study will be stated, as well as their statistical evaluation; and Conclusions, where those that are directly supported by the data will be mentioned, along with their clinical applicability. Equal emphasis should be given to positive and negative findings of similar scientific interest. After the abstract, the keywords will be included, from 3 to 10 in total, with the aim of complementing the information contained in the title and helping to identify the work in the bibliographic databases. For the keywords, terms equivalent to those obtained from the list of descriptors in Health Sciences of the Index Medicus should be used. (Medical Subjects Headings, MeSH, of the U.S. National Library of Medicine-NLM-), available at :www.nlm.nih.gov/mesh/meshhome.html.

1.3. TEXT OR BODY OF THE MANUSCRIPT. ORIGINALS. The maximum length is 16 pages and up to 5 tables or figures will be accepted. They should be structured as follows:

1.3.1. Introduction. The objectives of the work should be clearly mentioned and their foundation summarized, without extensively reviewing the subject. Only those references that are strictly necessary will be cited.

1.3.2. Material and methods. In this section, the place, time and population of the study must be specified. The authors must include information on how the design was carried out, on how the subjects were selected; and on all the techniques, analytical determinations and other tests or measurements carried out. All this with enough detail so that other researchers can reproduce the study without difficulties. At the end of this section, the type of statistical analysis used must be indicated, specifying the confidence interval. The studies will have the corresponding experiments or control groups; otherwise, the measures used to avoid bias will be explained and their possible effect on the conclusions of the study will be commented on. If it is an original methodology, the reasons that have led to its use will be explained and its possible limitations will be described. The names of the patients should not be shown nor include any data that could lead to their identification. With regard to drugs, the generic name of the drugs used in the study will be used, avoiding their commercial names and detailing as much as possible the prescribed dose, the route of administration and the time of administration. Likewise, the ethical standards followed by the researchers will be indicated, both in studies in humans and in animals. Studies in human beings must have the express approval of the Local Ethics and Clinical Trials Committee in question. The authors should mention that the procedures used in patients and controls have been carried out after obtaining informed consent.

1.3.3. Results. The results must be presented following a logical and concordant sequence in the text and in the tables and figures. Data can be displayed in tables or figures, but not simultaneously in both. Important observations should be highlighted in the text, without repeating all the data presented in the tables or figures. The presentation of the results should not be mixed with their discussion.

1.3.4. Discussion. This is a discussion of the results obtained in the work and not a review of the subject in general. The authors must highlight the new and important aspects that their work contributes to and the conclusions that are derived from them. Data appearing in the results section should not be repeated in detail. In the discussion, the authors must emphasize the concordances or disagreements of their findings and their limitations, comparing them with other relevant studies identified through the respective bibliographical references. At the end, the conclusions obtained must be related to the objective(s) of the study as stated in the introduction. Avoid formulating conclusions that are not supported by the findings, as well as supporting these conclusions in other works not yet finished. If necessary, the authors can propose new hypotheses, but these must be clearly identified as such. Where appropriate, authors may advise recommendations.

1.3.5. Bibliography. This should not exceed 40 bibliographic citations. Only those citations that are considered essential and have been read by the authors will be included. All references must be cited in the text consecutively according to the order of appearance and identified by referencing in superscript Arabic numerals. References that are cited only in tables or legends must be numbered according to the sequence established by the first identification in the text of the tables or figures. The citation of the bibliography will be done according to the Vancouver style developed by the ICMJE, available at: https://www.nlm.nih.gov/bsd/uniform_requirements.html

1.3.6. Tables. These are numbered consecutively with Arabic numerals in the same order of appearance in the text and will be included in the manuscript, at the end of it, after the bibliography. They will be prepared with one and a half spaces, like the rest of the manuscript, and the font should not be changed. They will be identified with the corresponding numbering and a brief but sufficiently explanatory title at the top. The legend of the table must allow its content to be understood without the reader having to go to the text to do so. Each column of the table must contain a short header. The necessary explanatory notes must be included at the bottom of the table and use calls in the form of lowercase letters in superscript and in alphabetical order (a, b, c) or symbols such as asterisk (*), hash (#), and others, also in superscript, as long as they are well distinguishable from each other. Statistical measures of variation, such as the standard deviation and standard error of the mean, should be included in the tables. Only decimals with clinical significance will be used; for example, blood glucose of 89.67 should be expressed as 89.7.

1.3.7. Figures. All graphics, photographs and drawings are considered figures. The figures will be identified with Arabic numerals that coincide with their order of appearance in the text. The captions of the figures will be prepared with a space and a half on separate pages. The legends and footnotes of the figures must contain enough information to be able to interpret the data presented without having to resort to the text. For the explanatory notes at the foot of the figure, callouts in the form of lowercase letters or superscript symbols will be used, as indicated above for the tables. In the photographs of histological preparations, the type of staining and the magnification must appear. The minimum resolution of the images must be 300 dpi (dots per inch).

CLINICAL NOTES. They must be accompanied, in addition to the abstract, by a brief introduction (maximum, 150 words); both texts prior to the description of the case. The maximum length of the text will be 5 pages (1,750 words, 10,650 characters with spaces). Up to two figures and two tables will be accepted. It is advisable that the number of signatories does not exceed six and that no more than 20 bibliographical references are included.

BRIEF ORIGINALS. These works must have a maximum length of 5 pages of text, must not exceed 10 bibliographic references or provide more than 3 illustrations (figures, tables or images). The maximum number of signatories must not exceed 6. Its structure will be the same as that of the original articles.

OSTEOLOGY IMAGES. These must be accompanied by an explanatory text whose maximum length will be 2 pages.

REVIEWS. They will be presented with a maximum length of 12 pages (4,200 words, 25,560 characters with spaces) and a maximum of 60 citations. A maximum of 4 figures and 5 tables will be admitted, which must clearly contribute to a better understanding of the text. They will have a final section of conclusions of approximately one page in length.

EDITORIAL LETTERS. They will have a maximum length of 4 pages (2,100 words, 12,780 characters with spaces), without tables or figures and a maximum of 30 bibliographic citations.



After the Publisher receives a manuscript, the editors acknowledge receipt by email as soon as possible and will send it to the Director who registers it and assign it a reference number. This reference number will be notified to the author responsible for the correspondence, indicating the process of anonymous peer review, which will be completed within a period of 3 months. In any case, prior to the start of the review process itself, the Publisher will verify the authors’ compliance with the publication regulations. In the case of significant non-compliance with these rules, the manuscript will be returned to the authors before starting the review process, requesting that they correct the errors detected. In the event that the manuscript is suitable for review or, where appropriate, once the errors have been corrected, the Management will contact the potential reviewers that the Management Committee has selected. Authors are welcome to suggest names of individuals they believe are appropriate and qualified to impartially review their manuscript. In such a case, the authors’ suggestion will include, in addition to the identification of the people proposed and their contact form, the specific reasons why they consider that they can objectively evaluate the article. They may also indicate those reviewers who do not want them to evaluate the manuscript, and must also sufficiently justify this information. The management of these data and circumstances will be absolutely confidential by the ROMM management team. Once potential reviewers have agreed, they will have approximately 4 weeks to complete the report. After receiving the reports and based on them, the Steering Committee will make a decision, which may be: 1) accept the manuscript for publication; 2) give authors the opportunity to review and make corrections; or 3) reject the text. In case there is no clear decision due to contradictory reports, the management will send the manuscript to the Editorial Board, which will make a final decision. A letter about the final decision and the pertinent comments, if any, will be sent to the corresponding author from the Editorial Office. The manuscripts that have been reviewed and corrected after a first evaluation will be evaluated again by the same reviewers to determine if the authors have observed and satisfactorily carried out the suggestions and considerations proposed by the reviewers or, where appropriate, the Editorial Committee.  After this new evaluation, the manuscript will be definitively accepted or rejected. If the work is accepted, a final style review will be carried out by the Management, which will send it to the editors for layout. Prior to its online publication, the authors will be asked to accept the proofs or galley proofs in order to correct any possible errors, after which it will be published immediately on the ROMM website.

All editorial correspondence with the reviewers and the corresponding author, carried out during the review process, will be carried out exclusively by email.

Obligations of reviewers Critical and confidential review of manuscripts is an essential element of research publications. Every scientist has an obligation to contribute to the peer review process as a reviewer. The reviewers will not receive any remuneration for their work. The reviewers, who must be experts in the subject on which the work to be reviewed is based, will assume the commitment to carry out a scientific and literary evaluation of the research that is proposed to them according to their knowledge, skills and experience; all this in a fair and impartial manner. In order to facilitate the rapid exchange of scientific results, it is the obligation of each reviewer to respond diligently to requests for review and to complete their tasks promptly and, ideally, within the time suggested by management. If there is any circumstance that causes a significant delay in the review, the reviewer will notify this as soon as possible in order to be replaced by another reviewer and thus not hinder the overall review process. Reviewers should not review a manuscript when any of the following circumstances occur: 1) if they do not consider themselves competent to evaluate the research described, 2) if they have evidence or certain suspicion that, despite anonymity, they know the authorship of the manuscript and believe that there may be a conflict of interest or a personal or professional relationship with the author(s) that could bias the evaluation, or 3) if there is any other situation that could prevent an objective and impartial judgment of the proposed review. Working at the same institution as one of the authors does not in itself represent a case of conflict of interest. Reviewers should strive to provide accurate, detailed and, if possible, constructive criticism. The review should be properly referenced, especially if it is unfavourable. The reviewer must also take into account whether the works of other authors are cited correctly. If reviewers detect any substantial similarity of the manuscript with previously published articles or with manuscripts simultaneously submitted for review in other journals, they must immediately inform the Publisher.

As correspondence with reviewers is exclusively by email, reviewers endeavour to report changes in their email address to the ROMM Editorial Office (redaccion@romm.es). The list of annual reviewers is published on the ROMM website. Also, in the last issue of each year, the names of the reviewers who have specifically collaborated in that year are published.



When sending e-mail work, the author ensures that all material submitted to this Journal for publication is original and has not been previously published or simultaneously submitted to any other Journal for publication. The author also warrants that the work complies with the Data Protection Act and has obtained the prior written consent of patients or their relatives for publication Data Protection Act and has obtained the prior written consent of patients or their relatives for publication.



The potential conflicts of interest of the authors must be stated on the title page and authors (see 1. Manuscripts section, 1.1. title page and authors). The authors of the works must disclose any relationship they may have with any organization with a financial interest, direct or indirect, in the subject matter or materials related to the manuscript that could influence the published work. In case of doubt about what could be a conflict of interest, the authors should inform about all those that could potentially be. The same will apply to authors of both editorials and reviews. Information on potential conflicts of interest will be provided to reviewers and will be published at the discretion of the Steering Committee.



For the purposes of the provisions of the Intellectual Property Law, the authors of the published texts are responsible for any liability that may arise from possible attacks on intellectual property rights. They must assume the conflicts that may arise from this property.

Works sent to the Journal for publication must respect the principles of intellectual ethics, ruling out scientific fraud and plagiarism. Scientific fraud is understood, among other circumstances, as the fabrication, falsification or omission of data from the experiments described in the text that serve to draw general conclusions, the lack of reference to the sources used or the origin of those cited and their incorrect mention, the appropriation of other people’s works, the assumption of citation, ideas or other people’s conclusions without mentioning their true authors, the duplication and unaware publication of the original article and the conflicts of authorship mentioned in these guidelines.

^Top of page